A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes. ccm [Internet]. 2025 Dec. 5 [cited 2026 Sep. 17];9(6):491-8. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16664